List prices for older versions of insulin are rising, and prices are even higher for newer versions of the drug, Carolyn Johnson reports for the Washington Post. However, drugmakers note that the drugs' list prices often don't reflect actual patient costs.
Print All Daily Briefing Article from
Have a Question?
Ask our experts a question on any topic in health care by visiting our member portal, AskAdvisory.